Search
Now showing items 1-1 of 1
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.
(2015)
BACKGROUND: Real-world prescription pathways leading to triple therapy (TT) (inhaled corticosteroid [ICS] plus long-acting β2-agonist bronchodilator [LABA] plus long-acting muscarinic antagonist) differ from Global initiative ...